Douša M - Search Results

1

Quality by Design as a risk-based strategy in pharmaceutical analysis: Development of a liquid chromatography-tandem mass spectrometry method for the determination of nintedanib and its impurities.

Pasquini B, Orlandini S, Furlanetto S, Gotti R, Del Bubba M, Boscaro F, Bertaccini B, Douša M, Pieraccini G. Pasquini B, et al. Among authors: dousa m. J Chromatogr A. 2020 Jan 25;1611:460615. doi: 10.1016/j.chroma.2019.460615. Epub 2019 Oct 10. J Chromatogr A. 2020. PMID: 31630831

2

High-performance liquid chromatographic determination of dihydroergocristine in a pharmaceutical formulation with fluorescence detection.

Dousa M, Dubovská M. Dousa M, et al. J AOAC Int. 2010 Jan-Feb;93(1):97-101. J AOAC Int. 2010. PMID: 20334170

3

Fast HPLC method using ion-pair and hydrophilic interaction liquid chromatography for determination of phenylephrine in pharmaceutical formulations.

Dousa M, Gibala P. Dousa M, et al. J AOAC Int. 2010 Sep-Oct;93(5):1436-42. J AOAC Int. 2010. PMID: 21140654

4

Direct analysis in real time--high resolution mass spectrometry as a valuable tool for the pharmaceutical drug development.

Srbek J, Klejdus B, Douša M, Břicháč J, Stasiak P, Reitmajer J, Nováková L. Srbek J, et al. Among authors: dousa m. Talanta. 2014 Dec;130:518-26. doi: 10.1016/j.talanta.2014.07.007. Epub 2014 Jul 21. Talanta. 2014. PMID: 25159441

5

Enantioseparation and impurity determination of ambrisentan using cyclodextrin-modified micellar electrokinetic chromatography: Visualizing the design space within quality by design framework.

Orlandini S, Pasquini B, Caprini C, Del Bubba M, Douša M, Pinzauti S, Furlanetto S. Orlandini S, et al. Among authors: dousa m. J Chromatogr A. 2016 Oct 7;1467:363-371. doi: 10.1016/j.chroma.2016.06.082. Epub 2016 Jul 1. J Chromatogr A. 2016. PMID: 27425759

6

HPLC/UV/MS method application for the separation of obeticholic acid and its related compounds in development process and quality control.

Douša M, Slavíková M, Kubelka T, Černý J, Gibala P, Zezula J. Douša M, et al. J Pharm Biomed Anal. 2018 Feb 5;149:214-224. doi: 10.1016/j.jpba.2017.11.018. Epub 2017 Nov 4. J Pharm Biomed Anal. 2018. PMID: 29126083

7

Chiral capillary zone electrophoresis in enantioseparation and analysis of cinacalcet impurities: Use of Quality by Design principles in method development.

Pasquini B, Orlandini S, Villar-Navarro M, Caprini C, Del Bubba M, Douša M, Giuffrida A, Gotti R, Furlanetto S. Pasquini B, et al. Among authors: dousa m. J Chromatogr A. 2018 Sep 21;1568:205-213. doi: 10.1016/j.chroma.2018.07.021. Epub 2018 Jul 5. J Chromatogr A. 2018. PMID: 30005942

8

Quantification of 2-aminoisobutyric acid impurity in enzalutamide bulk drug substance using hydrophilic interaction chromatography with fluorescence detection.

Douša M. Douša M. J Pharm Biomed Anal. 2019 Feb 5;164:296-301. doi: 10.1016/j.jpba.2018.10.049. Epub 2018 Oct 31. J Pharm Biomed Anal. 2019. PMID: 30412802

9

HILIC-MS determination of dimethylamine in the active pharmaceutical ingredients and in the dosage forms of metformin.

Douša M, Jireš J. Douša M, et al. J Pharm Biomed Anal. 2020 Nov 30;191:113573. doi: 10.1016/j.jpba.2020.113573. Epub 2020 Aug 22. J Pharm Biomed Anal. 2020. PMID: 32896809

10

Insight into the formation of N-nitrosodimethylamine in metformin products.

Jireš J, Kalášek S, Gibala P, Rudovský J, Douša M, Kubelka T, Hrubý J, Řezanka P. Jireš J, et al. Among authors: dousa m. J Pharm Biomed Anal. 2021 Feb 20;195:113877. doi: 10.1016/j.jpba.2020.113877. Epub 2020 Dec 30. J Pharm Biomed Anal. 2021. PMID: 33422831

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page